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O meningioma é o tumor intracraniano mais 
comum na base do crânio e o seu diagnóstico 
imagiológico é habitualmente claro, mas outras 
lesões podem apresentar-se com achados 
semelhantes.
Um homem de 60 anos apresentou-se com 
perda de memória e alterações comportamentais. 
Efectuou Tomografia Computorizada (TC) e 
Ressonância Magnética (RM) de crânio que 
demonstraram uma lesão extra-axial de base dural 
na fossa média. A lesão possuía forte realce com 
natureza hipervascular, vasos periféricos e edema 
vasogénico do parênquima cerebral adjacente.
Embora a lesão de base dural mais comum do 
sistema nervoso central (SNC) seja o meningioma, 
devem-se considerar outros diagnósticos 
diferenciais, particularmente na presença de 
características de imagem atípicas. Nestes 
incluem-se metástases, linfoma e leucemia, lesões 
histiocíticas, sarcoidose e hemangiopericitoma. 
Com base nos achados de imagem, sugerimos o 
diagnóstico de hemangiopericitoma e o doente 
foi sujeito a cirurgia de ressecção tumoral e 
radioterapia adjuvante, encontrando-se um 
pequeno resíduo tumoral estável nos estudos de 
seguimento.
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Abstract
Meningioma is the most common intracranial 
tumor affecting the skull base and the diagnosis 
is usually straightforward on imaging studies. 
However, other lesions may present similar 
findings.
A 60 year-old-man presented with memory loss 
and behavioral changes. Computed Tomography 
(CT) and Magnetic Resonance (MR) imaging 
disclosed an extra-axial, dural-based lesion of  
the middle cranial fossa. The lesion was strongly 
enhanced and of  hypervascular nature, peripheral 
vessels and vasogenic edema of  the adjacent 
brain parenchyma. 
Although the most common dural-based lesion 
of  the central nervous system (CNS) is the 
meningioma, radiologists should be aware of  
other differential diagnoses, particularly when 
facing atypical imaging features. These comprise 
metastases, lymphoma and leukemia, histiocytic 
lesions, sarcoidosis and hemangiopericytoma. 
Based on imaging findings we were able to 
suggest the hemangiopericytoma diagnosis and 
the patient was subject to tumoral resection 
surgery and adjuvant radiotherapy. A small 
tumoral residue remains stable on follow-up 
studies.
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Radiological Case Report / Caso Clínico
Introduction
Meningioma, a benign tumor originating from arachnoid cap 
cells, is the most common intracranial tumor representing 
33.8% of  all primary brain tumors diagnosed in the United 
States.1,2 Often incidentally discovered when investigating 
non-specific neurological symptoms, diagnosis is usually 
performed on cross-sectional imaging (CT and MR). However, 
other rarer meningeal-related lesions may be easily overlooked 
as they mimic meningioma features on imaging studies. 
Hemangiopericytoma is one such lesion, representing less than 
0.4% of  CNS tumors.3
This rare tumor has recently been reclassified as being the same 
entity as solitary fibrous tumor of  the dura.4,5 Usually, being a 
more aggressive lesion than a meningioma, with a high rate of  
local recurrence and possible distant metastases, it is crucial 
that the diagnosis is made as early as possible and that a 
close and prolonged follow-up is performed.6
Case report
A 60-year-old man presented with short and long-term 
memory loss and behavioral changes which had been slowly 
progressing in the last 2 years. Also, discreet personality 
changes were recently observed by close relatives. Family 
history was irrelevant. The remainder neurological and 
physical examination were only remarkable for slight 
hypoesthesia of  the left face. 
A non-contrast-enhanced CT of  the brain revealed a 
large, spontaneously hyperdense extra-axial mass, in the 
left middle cranial fossa, with lobulated contours (Fig. 1), 
extending into the infratemporal fossa through the greater 
20
sphenoid wing and foramen ovale. The lesion showed 
mass-effect and vasogenic edema of  the surrounding 
temporal lobe. 
On MR, the lesion was discreetly hyperintense on T1-
weighted and isointense to gray matter on T2-weighted 
images (Fig. 2). Multiple vascular flow-voids were seen 
both at the periphery and central core of  the lesion, 
representing prominent branches from the middle and 
posterior left cerebral arteries. The surrounding brain 
parenchyma showed vasogenic edema. After gadolinium 
administration, strong homogeneous enhancement and 
a “dural tail” sign were seen.  There was no restricted 
diffusion. Additional MR spectroscopy (MRS) showed a 
myoinositol peak and no alanine peak. With a presumed 
diagnosis of  hemangiopericytoma, the patient underwent a 
chest CT and a Positron emission tomography (PET-CT), 
which were both negative.
Surgical resection of  the tumor was performed through 
a left temporal craniotomy. On histopathology the tumor 
was composed of  polygonal cells arranged in a solid 
pattern (Fig. 3A). Focally, some collagen fibers were 
seen (Fig. 3B). The tumor was highly vascularized with 
numerous capillary blood vessels, often with ‘staghorn’ 
configuration (Fig. 3C). The neoplastic cells had indistinct 
cytoplasmic contours and round to oval nuclei. Three 
mitotic figures in 10 high-power fields were counted (Fig. 
3D). Immunohistochemistry revealed reactivity with CD34 
(Fig. 3E), BCL2 (Fig. 3F) and vimentin and no expression 
of  EMA, S100 protein or progesterone receptor. Diagnosis 
of  hemangiopericytoma (WHO Grade II) was made.
Post-surgical MR disclosed complete resection of  the 
intracranial component and a 12-mm tumor residue 
adjacent to foramen ovale and upper masticator space. The 
patient received adjuvant radiotherapy (SBRT), in a total 
dose of  50Gy (2,5Gy/session).
Upon treatment completion, the patient maintained short 
memory deficit and hypoesthesia of  the left face. After 
a two-year follow-up the small tumor residue remained 
unchanged with no signs of  local recurrence. Also, no 
distant metastases were noted on serial PET-CT and chest 
CT. 
Figure 1 - Non-contrast-enhanced head CT 
scan, with multiplanar reformats on the axial 
(A), sagittal (B) and coronal (C) planes. A and 
B shows soft-tissue window and C shows bone 
window. There is a large apparently extra-axial 
mass in the left middle cranial fossa (black 
arrows), spontaneously hyperdense with a 
lobulated contour. The mass extends through 
the left central skull base, causing destruction 
of  the greater sphenoid wing (C, black circle). 
Note the hypodensity of  the surrounding 
brain parenchyma (white arrows), due to 
vasogenic brain edema. 
Figure 2 – Contrast-enhanced MR study. The lesion (white arrows) is discreetly hyperintense on sagittal T1-weighted images (A) and 
isointense to gray matter on axial Proton-density-weighted: PDW (B) images. On coronal T2-weighted images (E) and axial Fluid-
attenuated inversion recovery: FLAIR (F) images, the lesion (white arrows) is isointense to gray matter. Note the extensive vascular flow 
voids surrounding the lesion (black arrows). There is mass effect with a rightward tilt of  the mesencephalon, effacement of  the ambiens 
cistern and inferior uncal herniation (E and F, black dashed arrows). The surrounding brain parenchyma reveals high signal intensity (E 
and F, white dashed arrows) due to vasogenic edema. On Diffusion-weighted imaging: DWI the lesion shows high ADC values (C, white 
arrow) and low signal intensity on b1000 (D, white arrow). Axial (G) and coronal (H) contrast-enhanced fat-suppressed T1-weighted images 
reveal intense and homogeneous enhancement (white arrows). The inferior extension to the infratemporal fossa and the surrounding 
neovascularization is clearly depicted (H, black dashed arrow). Also note the linear enhancement or the surrounding dura - “dural tail” sign 
(H, white dashed arrow).
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Discussion
The imaging diagnosis of  dural-based lesions is perceived 
as straightforward, although this is not always the case. 
Typical imaging features of  meningioma: “dural tail 
sign”, regular contours and adjacent bone hyperostosis, 
signal intensity similar to gray matter on T1-weighted 
and T2-weighted MR images along with vivid contrast 
enhancement, should be enough to confidently diagnose a 
meningioma in an otherwise “healthy” patient. However, in 
a patient suffering from other co-morbidities, especially a 
malignancy, a high index of  suspicion for dural metastasis 
must be maintained, even if  the lesion looks “typical”. 
In the case reported, working diagnoses were atypical 
meningioma and hemangiopericytoma. Both lesions appear 
on imaging studies as extra-axial masses with a broad dural 
base and “dural tail” sign, with signal intensity similar to 
gray matter, often absent restriction on diffusion-weighted 
images and homogeneous contrast enhancement. 
Imaging features favoring hemangiopericytoma included 
the lobulated contours, peri-lesional neovascularization, 
lytic bone destruction of  the central skull base and a high 
myoinositol peak without alanine peak, on MRS.6,7 
Other lesions which can present themselves as broad dural-
based masses are summarized on table 1.
Hemangiopericytoma is a rare neoplasm thought to arise 
from the Zimmermann pericytes surrounding capillaries 
and postcapillary venules that is more common in 
musculoskeletal system and skin and represents less than 
0.4% of  CNS tumors.6 Its typical age of  appearance is 38-
42 years, while meningiomas occur frequently in slightly 
older patients (50 year-olds).6,8 These are highly cellular 
tumors, composed of  closely packed cells with scant 
cytoplasm and interrupted by gaping capillary caliber 
vessels with a branching “staghorn” pattern, as shown in 
Figure 3 – Lesion histology, Hematoxylin and eosin stain: H&E (A 20x, B and C 200x). There is compact tumor, alternating hypo (arrow) 
and hypercellular (asterisk) areas (A). Note focal collagen deposition (B, arrow) and the “staghorn” vessel (C, asterisk). D (H&E 400x) 
shows a typical mitotic figure (arrow). CD34 immunohistochemistry (E, 100x) shows immunoreactive neoplastic cells in some areas 
(asterisk), with a rich vascular network. There is also BCL2 immunoreactivity in neoplastic cells (F, 100x, asterisk).
the present case (Fig. 3A-D). Hemangiopericytomas can 
show malignant behavior, with metastases occurring in 
20% of  the cases, usually in the liver, lung and bone.6,9 
Recurrence rates are high and there is a known long-term 
risk for metastatic disease.4 Nowadays, it is considered 
part of  a spectrum of  lesions, as described in The 2016 
World Health Organization Classification of  Tumors 
of  the Central Nervous System, which attributed 3 
grades for the combined entity hemangiopericytoma/
solitary fibrous tumor: grade I (solitary fibrous tumor); 
grade II (hemangiopericytoma) and grade III (anaplastic 
hemangiopericytoma).4 Currently, immunophenotypic 
analysis, assessing for STAT6 expression and/or NAB2-
STAT6 fusion, further confirms the diagnosis. 
Recommended therapy is surgical resection and 
preoperative embolization may be considered, due to the 
high vascularization of  the tumor. These are followed 
by adjuvant radiotherapy in all WHO grade III and 
incompletely resected WHO grade II tumors to prevent 
recurrence (such as in the present case report). Long-term 
follow-up is recommended for early detection of  local 
recurrence and/or distant metastases.
Conclusion
Meningeal hemangiopericytomas are dural-based lesions 
with malignant behavior that should not be overlooked on 
imaging studies. A high degree of  suspicion along with the 
clinical history may help the diagnosis. Imaging features 
mimic those of  the much more common meningioma but 
the presence of  lobulated contours, vasogenic brain edema, 
strong arterial-like enhancement, presence of  multiple flow 
voids, adjacent bone erosion and a high myoinositol peak 
on MRS allow a pre-operative diagnosis and adequate 
patient management. Therapy consists of  surgical resection 
and adjuvant radiotherapy.
22
Mass lesions with broad dural base Distinctive features
Meningioma - hemispheric, well-defined borders
- “dural tail” sign
- signal intensity of  gray matter on all pulse sequences
- presence of  calcifications
- adjacent bone hyperostosis
- homogeneous enhancement 
- alanine peak on MRS
Hemangiopericytoma/ solitary fibrous tumor - lobulated contours
- neovascularization (flow voids)
- no calcifications
- local aggressiveness (vasogenic edema of  adjacent brain)
- lytic erosion of  adjacent bone
- vivid, homogeneous, arterial-like enhancement (on DCE-PWI)
- myoinositol peak on MRS
Dural metastasis - irregular margins
- high T2W signal intensity
- restricted diffusion
- usually multiple
- most frequently from breast, lung and prostate cancer
Primary dural lymphoma - indistinct brain-tumor interface
- low T2W signal intensity
- restricted diffusion (mADC< 1x10-3mm2/s)
Rosai-Dorfman disease - iso/hypo T2W signal intensity (often with central hypointensity)
- adjacent brain edema 
- cervical lymphadenopathy (common)
- fever, night sweats and weight loss
Erdheim-Chester disease - iso/hypo on T2W signal intensity
- associated involvement of  facial bones and orbits (common)
Melanocytic neoplasms - high T1W signal intensity
- iso/hypo T2W signal intensity
- susceptibility artifact on T2*/ SWI
Neurosarcoidosis - iso/hypo T2W signal intensity
- diffuse meningeal thickening or a focal mass
- often associated to systemic sarcoidosis
Abbreviations: MRS: magnetic resonance spectroscopy; DCE-PWI: dynamic contrast-enhanced perfusion weighted imaging; T2W: T2 weighted; 
T1W: T1 weighted; mADC: mean apparent diffusion coefficient; SWI: susceptibility weighted imaging.
Table 1 – Differential diagnosis of  mass lesions with a broad dural base
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